Wednesday, June 10, 2026

pharma Β· AML/MDS Β· Hepatocellular Carcinoma (HCC) Β· SNTI

Essential Pharma

Essential Pharma clinical programs β€” 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Egham, GB HQ
2000 Founded
111 Employees
Public company Type
SNTI Β· NYSE Ticker
Company details
Status
Public
HQ
Egham, GB
Founded
2000
Employees
111
Programs
2
Drugs
3
Patents
95
Intelligence Β· Clinical Programs

Essential Pharma projects

2 ClinicalTrials.gov programs sponsored by Essential Pharma.

Essential Pharma has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. SENTI-202

    Essential Pharma Limited

    AML/MDS

    phase 1 mab active

    1 trial
  2. SN301A

    Essential Pharma Limited

    Hepatocellular Carcinoma (HCC)

    phase 1 mab active

    1 trial

Frequently asked questions

How many clinical projects does Essential Pharma have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.